Covidien expands voluntary recall of brain sensors

Following up on a November 2011 voluntary recall of nine lots of its BIS bilateral brain sensors, Covidien has expanded the lot count to 58.

In a Jan. 19 announcement, the company said the recalls owe to a modification that could result in inaccurate readings of electroencephalogram (EEG) information.

The company said no reports have come in on patient injuries related to the recalled products, and that the recall only affects lot numbers manufactured during particular time periods.

For specifics on affected devices, click here.
Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

Trimed Popup
Trimed Popup